Expert Review of Anti-infective Therapy ( IF 4.2 ) Pub Date : 2021-07-13 , DOI: 10.1080/14787210.2021.1944103 Manoj Kumar Sarangi 1 , Sasmita Padhi 1 , Shrivardhan Dheeman 2 , Santosh Kumar Karn 3 , L D Patel 4 , Dong Kee Yi 5 , Sitansu Sekhar Nanda 5
ABSTRACT
Introduction
Coronavirus disease (COVID-19) was first reported in Wuhan, China, in late December 2019 and subsequently, declared a pandemic. As of 3 June 2021, 172,493,290 individuals have acquired COVID-19 and 3,708,334 patients have died worldwide, according to the World Health Organization.
Areas covered
This review explores epidemiology; virology; pathogenesis; genomic variations; mode of transmission; clinical occurrence; diagnosis; and treatment with antiviral agents, antibiotics, and supportive therapies. It covers a nanotechnology-based treatment approach and emphasizes the importance of herbal and marine antiviral drugs. The review attempts to explain current advances in research, prevention, and control of COVID-19 spread through artificial intelligence and vaccine development status under cosmopolitan consideration.
Expert opinion
While COVID-19 research is advancing at full capacity, the discovery of drugs or vaccines that can fight the pandemic is necessary. Human survival in such a critical situation will be possible only with the development of strong immunity by opting for exercise, yoga, and consumption of hygienic food and beverages. Therefore, education about COVID-19 lethality and its impact on livelihood is important. The pandemic has also shown positive effects on the environment, such as a significant reduction in environmental pollution and global warming and improvement in river water quality.